REQUEST A DEMO
Total
USD $0.00
Search more companies

Astellas Pharma Sp. z o.o. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Astellas Pharma Sp. z o.o. Profile Updated: September 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Astellas Pharma Sp. z o.o. is based in Poland. The head office is in Warsaw. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Astellas Pharma Sp. z o.o. was incorporated on July 20, 2001. It currently has a total number of 137 (2020) employees. From the latest financial highlights, Astellas Pharma Sp. z o.o. reported a net sales revenue increase of 4.35% in 2023. A growth of 26.21% was recorded in its total assets. The net profit margin of Astellas Pharma Sp. z o.o. increased by 0.76% in 2023.

Headquarters
Ul. Zwirki I Wigury 16C
Warsaw; Mazowieckie; Postal Code: 02-092

Contact Details: Purchase the Astellas Pharma Sp. z o.o. report to view the information.

Website: http://www.astellas.eu

Basic Information
Total Employees:
Purchase the Astellas Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Astellas Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Astellas Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Astellas Pharma Sp. z o.o. report to view the information.
Incorporation Date:
July 20, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astellas Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
4.35%
Total operating revenue
4.3%
Operating profit (EBIT)
1.9%
EBITDA
2.17%
Net Profit (Loss) for the Period
85.96%
Total assets
26.21%
Total equity
9.37%
Operating Profit Margin (ROS)
-0.04%
Net Profit Margin
0.76%
Return on Equity (ROE)
3.53%
Quick Ratio
-0.29%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?